FDA’s Sentinel System is engaged in numerous activities to protect and promote public health during the COVID-19 pandemic, ranging from monitoring the use of drugs, describing the course of illness among hospitalized patients, and evaluating the treatment impact of therapies actively being used under real-world conditions. Descriptions of efforts led by the Center for Drug Evaluation and Research are shown below. Please visit the links to learn more about each area of activity and also visit:
FDA Sentinel System's Coronavirus (COVID-19) Activities
The purpose of this project is to identify promising sources of electronic health records to strengthen the Sentinel System in areas of pediatric, cancer, pregnancy, birth outcomes, and...